预测左心室功能下降后新发病的左捆分支区块左心室功能下降
Dylan Goings1, Patricia Carey1, Tristan Meier2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Heart rhythm
|November 20, 2025
概括
人工智能衍生的心电图标志物预测左心室喷射分数下降在左捆分支阻塞的患者. 这有助于早期发现和干预心脏功能障碍.
科学领域:
- 心脏病学 心脏病学
- 人工智能在医学中的应用
- 医学诊断 医学诊断 医学诊断
背景情况:
- 左子分支阻塞 (LBBB) 与左心室缩功能障碍的风险增加有关.
- 早期识别高风险的LBBB患者对于及时管理至关重要.
研究的目的:
- 在LBBB患者中确定左心室射出分数 (LVEF) 显著下降的预测因素.
- 使用临床,心声和心电图 (ECG) 数据进行预测.
主要方法:
- 对769名新发LBBB和保存LVEF (≥50%) 的患者的回顾性分析.
- 考克斯比例危险回归以确定≥20%的LVEF下降的预测因素.
- 构建一个风险预测模型.
主要成果:
- 31.5%的患者在4.9年的中位数中经历了≥20%的LVEF下降.
- 对LV系统性和扩张性功能障碍的AI衍生的心电图分数独立预测LVEF下降.
- 预测模型显示了适度的区分能力 (C指数为0.615-0.70).
结论:
- 对于LV系统性和扩张性功能障碍的AI衍生的心电图标记预测新发性LBBB的未来LVEF下降.
- 心声学参数可以进一步增强风险分层.
- 该框架支持对LBBB患者的监测和早期干预.
更多相关视频
06:34Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
4.5K
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
3.4K
相关概念视频
Mitral Stenosis I: Introduction
420
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420
Heart Failure Drugs: β-Blockers
741
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
741
Cardiomyopathy II: Dilated Cardiomyopathy
449
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Heart Failure II: Pathophysiology
693
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
693
Cardiomyopathy III: Hypertrophic Cardiomyopathy
378
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Mitral Stenosis II: Clinical features and Diagnostic Tests
201
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
201
